TDP-43
Asset
Departitions pathological cytoplasmic TDP43 condensates and restores TDP-43 splicing across diverse ALS genotypes.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2ALS
Preclinical, dewpointx.com, 10 Oct 2026
Related neurodegenerative diseases
Preclinical, dewpointx.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors8
Every asset’s record: target, stage, trials and the evidence behind it.